Pop Test Oncology/Palisades Therapeutics Press Releases - EIN Presswire

Published on October 19, 2026 - 13:45 GMT

Palisades Therapeutics Highlights a Shared Inflammatory Mechanism Across Chronic Diseases in Frontiers in Pharmacology

PT150 clinical experience & next-generation PT157 research support exploration of selective glucocorticoid receptor modulation across diverse therapeutic areas CLIFFSIDE PARK, NJ, UNITED STATES, October 19, 2026 /⁨EINPresswire.com⁩/ -- Pop Test …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on April 14, 2026 - 13:30 GMT

Palisades Therapeutics Secures European Composition‑of‑Matter Patent for TPR1, Now in Ph 2 USDA Citrus Greening Trials

USDA‑funded grove studies of TPR1 target a multibillion‑dollar crop loss problem while the new EPO patent locks in protection for the core molecule CLIFFSIDE PARK, NJ, UNITED STATES, April 14, 2026 /⁨EINPresswire.com⁩/ -- Pop Test Oncology LLC, operating …

Distribution channels: Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry ...

Published on April 9, 2026 - 13:15 GMT

Palisades Therapeutics’ PT150 Emerges as First‑in‑Class 'Metabolic Setpoint Modifier' to Lock In GLP‑1 Weight Loss

Ph 2-ready oral PT150 reduces post semaglutide weight regain in preclinical models with no meaningful drug interaction risk, enabling rapid combination trials CLIFFSIDE PARK, NJ, UNITED STATES, April 9, 2026 /⁨EINPresswire.com⁩/ -- Pop Test Oncology LLC, …

Distribution channels: Banking, Finance & Investment Industry, Beauty & Hair Care ...

Published on February 19, 2026 - 14:30 GMT

Palisades Therapeutics Receives FDA Clearance to PROCEED with Phase 2a PTSD Trial of PT150 in U.S. Veterans

DoD-Funded Study Accelerates Novel PTSD Mechanism into Trials; Proven Alcohol Safety Profile De-Risks Program for Patients with Comorbid Alcohol Use Disorder CLIFFSIDE PARK, NJ, UNITED STATES, February 19, 2026 /⁨EINPresswire.com⁩/ -- Pop Test Oncology …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on October 21, 2025 - 13:45 GMT

Palisades Therapeutics Demonstrates Breakthrough Anti-Metastatic Activity in Advanced Prostate Cancer Models

Novel Compounds Show Superior Efficacy to Standard-of-Care Enzalutamide in 5-Day Zebrafish Platform Study CLIFFSIDE PARK, NJ, UNITED STATES, October 21, 2025 /⁨EINPresswire.com⁩/ -- Pop Test Oncology LLC, operating as Palisades Therapeutics, today …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on September 4, 2025 - 13:15 GMT

Revolutionary Science Meets Entrepreneurial Excellence

Palisades Therapeutics, The Virtual Pharma Model Redefining Drug Development-15 Years of Breakthrough Innovation Without the Overhead CLIFFSIDE PARK, NJ, UNITED STATES, September 4, 2025 /⁨EINPresswire.com⁩/ -- In an industry where walls are built faster …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on August 19, 2025 - 13:15 GMT

Palisades Therapeutics Announces Groundbreaking Clinical Results for its PT150 Drug, the Exemplar of its Platform

Oral Glucocorticoid Receptor Antagonist Demonstrates Superior Efficacy and Safety Profile for Multiple Therapeutic Applications CLIFFSIDE PARK, NJ, UNITED STATES, August 19, 2025 /⁨EINPresswire.com⁩/ -- Pop Test Oncology LLC, operating as Palisades …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on April 24, 2025 - 14:00 GMT

Palisades Therapeutics Unveils Breakthrough Multi-Mechanistic Data for PT150 and PT157 in Resistant Cancers

Dual AR/GR Antagonism, Metabolic Reprogramming, and Lysosomal Bypass Position PT150 and PT157 as Best-in-Class Oncology Candidates CLIFFSIDE PARK, NJ, UNITED STATES, April 24, 2025 /⁨EINPresswire.com⁩/ -- Pop Test Oncology LLC dba Palisades Therapeutics …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on April 3, 2025 - 13:30 GMT

Palisades Therapeutics Granted Breakthrough Patent for Novel Addiction Treatment

Next-Generation Compounds Show Promise CLIFFSIDE PARK, NJ, UNITED STATES, April 3, 2025 /⁨EINPresswire.com⁩/ -- Pop Test Oncology LLC dba Palisades Therapeutics proudly announces that the United States Patent and Trademark Office (USPTO) has granted a …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on February 20, 2025 - 14:30 GMT

Palisades Therapeutics Secures USPTO Patent For AI-Supported Portable Modular Artificial Liver

Revolutionizing Drug Development, Toxicity Screening, and Regenerative Medicine CLIFFSIDE PARK, NJ, UNITED STATES, February 20, 2025 /⁨EINPresswire.com⁩/ -- Pop Test Oncology LLC dba Palisades Therapeutics proudly announces that the United States Patent …

Distribution channels: Banking, Finance & Investment Industry, Chemical Industry ...

Published on January 3, 2023 - 14:45 GMT

Palisades Therapeutics Announces New Anti-Cancer Drug-PT162, a p53-Reactivating Cell Cycle Checkpoint Inhibitor

Newly Patented PT162 Induces Cancer Cell Cycle Arrest and/or Apoptosis by Restoring DNA-Binding Activity of Mutant p53 Protein CLIFFSIDE PARK, NJ, UNITED STATES, January 3, 2023 /⁨EINPresswire.com⁩/ -- One of the most common genetic changes resulting in …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on November 29, 2022 - 14:30 GMT

Cures Are Discovered By Entrepreneurial Companies Then Big Pharma Acquires Their Discoveries To Commercialize Success

Palisades Therapeutics Pioneers New Methodology to Fund Breakthrough Therapeutics and Devices CLIFFSIDE PARK, NJ, UNITED STATES, November 29, 2022 /⁨EINPresswire.com⁩/ -- The breakthrough drugs that provide cures to the public are created and developed by …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on September 30, 2022 - 13:30 GMT

PT150 FOR TREATMENT OF “LONG HAUL COVID” FEATURED POSTER AT THE NEUROSCIENCE CLINICAL-TRANSLATIONAL RESEARCH SYMPOSIUM

Palisades Therapeutics’ PT150 for symptoms associated with long haul COVID syndrome requested for possible inclusion in the NIH RECOVER COVID Studies CLIFFSIDE PARK, NJ, UNITED STATES, September 30, 2022 /⁨EINPresswire.com⁩/ -- The novel Coronavirus …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on August 9, 2022 - 13:45 GMT

PALISADES THERAPEUTICS PIONEERS NEW THERAPEUTIC FOR RARE DISEASE PARECHOVIRUS

Working in collaboration with CDC, NIH and FDA, Palisades makes its clinical stage therapeutics available to save children’s lives CLIFFSIDE PARK, NJ, UNITED STATES, August 9, 2022 /⁨EINPresswire.com⁩/ -- The Centers for Disease Control and Prevention …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 7, 2022 - 13:45 GMT

PILL TO PILL COMMUNICATION PROVIDES PRESCRIPTION COMPLIANCE, DRUG DELIVERY, SAFETY AND SAMPLING OF GUT BACTERIA

POP TEST/PALISADES THERAPEUTICS (PT) receives approval for 10th patent on SMART PILL TECHNOLOGY CLIFFSIDE PARK, NJ, UNITED STATES, July 7, 2022 /⁨EINPresswire.com⁩/ -- Major pharmaceutical companies are acknowledging the need for medication compliance …

Distribution channels: Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry ...

Published on June 7, 2022 - 13:45 GMT

Palisades Therapeutics’ Clinical Stage Drug PT150 Granted Patent for Parkinson’s Disease and Multiple Sclerosis

Patent Grant Expands Palisades’ Patent Portfolio for Neurodegenerative Diseases CLIFFSIDE PARK, NJ, UNITED STATES, June 7, 2022 /⁨EINPresswire.com⁩/ -- Palisades Therapeutics (PT) demonstrates in vivo neuroprotective effect of PT150 in the rotenone model …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on May 17, 2022 - 13:45 GMT

Palisades Therapeutics PT150 for treatment of “long haul COVID” neuro-psychiatric conditions

PT150 for depression, fatigue, memory dysfunction, and “brain fog” associated with long haul COVID syndrome CLIFFSIDE PARK, NJ, UNITED STATES, May 17, 2022 /⁨EINPresswire.com⁩/ -- Neuroinflammatory changes have been implicated in long haul COVID syndrome …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on March 1, 2022 - 15:00 GMT

Palisades Therapeutics Targets the IHOP Protein as a Biomarker to Detect Pancreatic Cancer and Enable PT Therapeutic

A collaborative effort between Palisades Therapeutics and Georgetown University could produce a pancreatic cancer breakthrough CLIFFSIDE PARK, NJ, UNITED STATES, March 1, 2022 /⁨EINPresswire.com⁩/ -- Early detection is key to life saving treatments for …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on February 22, 2022 - 15:00 GMT

Palisades Therapeutics’ Proprietary Dual Action Compound Reduces COVID-19 Viral Entry and Inflammatory Responses

Post-exposure prophylaxis for prevention of COVID-19 Acute Respiratory Distress Syndrome (ARDS) CLIFFSIDE PARK, NJ, UNITED STATES, February 22, 2022 /⁨EINPresswire.com⁩/ -- Palisades Therapeutics, working in collaboration with Prof. Richard Slayden and …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on February 15, 2022 - 15:00 GMT

Proprietary Dual Action Compound Could Save the Citrus Industry from Citrus Greening Plague

PT Compounds as a Method of Eradicating Citrus Greening and For Disrupting the Citrus Greening Life Cycle CLIFFSIDE PARK, NJ, UNITED STATES, February 15, 2022 /⁨EINPresswire.com⁩/ -- Palisades Therapeutics, working in collaboration with Central State …

Distribution channels: Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry ...